Title

Molecular Landscaping of AML: Are we relearning the Past or Informing the Future?

Document Type

Presentation

Presentation Date

10-8-2014

Abstract

Acute Myeloid Leukemia

  • AML comprises several distinct entities that are genetically and epigenetically heterogeneous
  • Cytogenetic and molecular heterogeneity is clinically relevant and has been used for risk-stratification, treatment selection and treatment guidance
  • However, this approach lacks of the necessary accuracy.

Presentation: 54 minutes